EUCTR2007-002223-32-IE
Active, not recruiting
Not Applicable
A multicentre, double-blind, randomised controlled trial of sodium bicarbonate to prevent acute kidney injury in patients undergoing cardiopulmonary bypass surgery. - Sodium Bicarbonate Study
Charité Universitaetsmedizin0 sites402 target enrollmentMarch 26, 2009
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cardiac surgical patients in whom the use of cardiopulmonary bypass is planned and having at least one ore more of the following risk factors for post-operative acute kidney injury• Age = 70 years• Preoperative plasma creatinine >120 µmol/L• Heart failure (NYHA class III / IV)• Insulin dependent diabetes mellitus• Valve surgery (with or without coronary artery bypass graft surgery)• Redo cardiac surgery
- Sponsor
- Charité Universitaetsmedizin
- Enrollment
- 402
- Status
- Active, not recruiting
- Last Updated
- 14 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Cardiac surgical patients in whom the use of cardiopulmonary bypass was planned and:
- •Written informed consent of patient
- •No present pregnancy
- •Highly effective contraception in women with childbearing potential (Pearl index \< 1\)
- •No participation in another clinical study (AMG) at the time of this study
- •and having at least one ore more of the following risk factors for post\-operative acute kidney injury
- •Age \= 70 years
- •Preoperative plasma creatinine \>120 µmol/L
- •Heart failure (NYHA class III / IV)
- •Insulin dependent diabetes mellitus
Exclusion Criteria
- •Cardiac surgical patients will not be considered eligible if:
- •The use of cardiopulmonary bypass is not planned (off\-pump cardiac surgery) or
- •An emergency operation is indicated (within 24 hours after first description of cardiac symptoms)
- •The above mentioned risk definition for post\-operative acute kidney injury is not fulfilled or
- •Women of childbearing age without highly effective contraception (PEARL\-Index \< 1%) or breastfeeding is present or
- •Contraindications against the study medication are present such as alkalosis or hypokalemia or hypernatremia or
- •Absent willingness to allow storage or circulation of coded data collected for study reason or
- •Patient is accomodated in an institution of mental disorders on judicial or magisterial behalf or
- •Patients participate in another clinical study (AMG) or
- •Pre\-operative end stage renal disease (serum creatinine \>300 µmol/L) is present or
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
The Rabeprazole and Esomeprazole Reflux Assessment TrialGastro-oesophageal reflux diseasePhysical Medicine / Rehabilitation - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12607000006448Janssen-Cilag Pty Ltd1,908
Completed
Not Applicable
A double-blind, randomised, controlled multicentre trial of three misoprostol regimens after pretreatment with mifepristone for termination of early pregnancyPregnancy and ChildbirthAbortionInduced abortionISRCTN81170837DP/UNFPA/WHO/World Bank - Special Programme of Research, Development and Research Training in Human Reproduction (HRP)2,100
Completed
Not Applicable
A double-blind, randomised, controlled multicentre trial of misoprostol treatment prior to Vacuum Aspiration for termination of early pregnancyISRCTN98284169DP/UNFPA/WHO/World Bank - Special Programme of Research, Development and Research Training in Human Reproduction4,984
Completed
Phase 4
An intervention study to determine if a longer duration of antibiotics (compared to shorter duration) improves the short and long term clinical outcomes of children hospitalised for pneumoniaPneumonia in childrenRespiratory - Other respiratory disorders / diseasesInfection - Studies of infection and infectious agentsPublic Health - Other public healthACTRN12616000046404Menzies School of Health Research324
Recruiting
Phase 3
Preventing recurrent acute lower respiratory infections in young Indigenous children using long-term, once-weekly azithromycin: a multicentre randomised controlled trialAcute lower respiratory infection in childrenRespiratory - Other respiratory disorders / diseasesInfection - Other infectious diseasesACTRN12619000456156Menzies School of Health Research160